News
Exclusive: Medivation succumbs to pressure to explore sale -sources
May 9, 2016 by elegant · Leave a Comment
U.S. cancer drug maker Medivation Inc has decided to explore a sale following a $9.3 billion acquisition offer from France's Sanofi SA and interest from other companies, people familiar with the matter said on Monday. Pfizer Inc and Amgen Inc are among the companies that have signed non-disclosure agreements with Medivation, which allow them to obtain confidential information about the company, the people said. Sanofi made its
Go here to read the rest:
Exclusive: Medivation succumbs to pressure to explore sale -sources